AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
APAL2020SC
OPEN TO ACCRUAL
PedAL Screening Trial - Developing new therapies for Relapsed Leukemias.
ARAR2331
OPEN TO ACCRUAL
Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)